Snake venom phospholipase A2 (PLA2) that displays local myotoxic activity. It also displays anticoagulant action in plasma and edema-inducing activities (PubMed:2327788, PubMed:9839670). In addition, it shows cytotoxic activity to a variety of cell types and bactericidal activity to a variety of Gram-negative and Gram-positive bacteria (PubMed:9654096, PubMed:9920486). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-glycero-3-phosphocholine + a fatty acid + H(+) Binds 1 Ca(2+) ion. High level of membrane cholesterol content reduces cytolytic activity, whereas low level of membrane cholesterol content increases cytolytic activity (PubMed:21506137). Monomer (PubMed:2327788). Homodimer; non-covalently linked (alternative/compact dimer conformation) (PubMed:28034717). Expressed by the venom gland. LD(50) is 5.6 mg/kg (95 ug/16-18 g) by intravenous injection into mice (PubMed:2873948). LD(50) is 25 ug/kg (0.42 ug/16-18 g) by intracerebroventricular injection into mice (PubMed:2873948). LD(50) is 8 mg/kg by intravenous injection into mice (PubMed:2327788). Belongs to the phospholipase A2 family. Group II subfamily. D49 sub-subfamily.